USNU Stock Overview
U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
U.S. NeuroSurgical Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.71 |
| 52 Week High | US$1.00 |
| 52 Week Low | US$0.08 |
| Beta | 0.33 |
| 1 Month Change | -11.25% |
| 3 Month Change | n/a |
| 1 Year Change | 787.50% |
| 3 Year Change | 78.17% |
| 5 Year Change | 208.83% |
| Change since IPO | 1,036.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| USNU | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -5.3% | 0.6% | 1.0% |
| 1Y | 787.5% | 2.2% | 21.9% |
Return vs Industry: USNU exceeded the US Healthcare industry which returned 2.2% over the past year.
Return vs Market: USNU exceeded the US Market which returned 21.9% over the past year.
Price Volatility
| USNU volatility | |
|---|---|
| USNU Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: USNU's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine USNU's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 2 | Alan Gold | www.usneuro.com |
U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. The company’s gamma knife is a stereotactic radio surgical device used to treat brain tumors and other malformations of the brain without invasive surgery. U.S.
U.S. NeuroSurgical Holdings, Inc. Fundamentals Summary
| USNU fundamental statistics | |
|---|---|
| Market cap | US$9.45m |
| Earnings (TTM) | -US$816.00k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-11.6x
P/E RatioIs USNU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| USNU income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$816.00k |
| Earnings | -US$816.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.061 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did USNU perform over the long term?
See historical performance and comparison